clinical trial · NCT05995405
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Aneurysmal Subarachnoid Hemorrhage (aSAH)GTX-104Nimotop 30 MG Oral Capsule
brief summary
The purpose of this study is to deliver nimodipine via IV directly into the bloodstream and to determine if this is as safe and tolerable as oral nimodipine capsules.
started
Oct 20, 2023
primary completion
Dec 1, 2024
completion
Dec 1, 2024
last updated
Oct 1, 2024
official title
Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol